Composition comprising as active ingredient L-carnitine in combination with Hydroxykynurennine-0-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation

Details for Australian Patent Application No. 2011223177 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Inventors Pescosolido, Nicola; Koverech, Aleardo

Agent Lord and Company

Pub. Number AU-A-2011223177

PCT Pub. Number WO2011/107334

Priority 10155501.9 04.03.10 EP

Filing date 10 February 2011

Wipo publication date 9 September 2011

International Classifications

A61K 31/205

A61K 31/7036

A61P 27/02 Drugs for disorders of the senses

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/107334 Priority application(s): WO2011/107334

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223190-Nutraceutical chocolate or compound chocolate product

2011223173-Two-part hinged needle magazine